This Beats Big Pharma’s Parkinson’s Drugs

Don’t let traditional doctors tell you that the only way to treat Parkinson’s disease is with their Big Pharma drugs.

These medications are designed to manage symptoms like tremors, slurred speech, shaking and trouble walking.

But the pills quit working after a while. And often leave a patient worse off than they were.

The drugs also have a laundry list of negative side effects… including nausea, vomiting, dizziness, involuntary movements, confusion and delusion.

But brand-new research from Thomas Jefferson University will turn how traditional doctors treat Parkinson’s disease on its head.1

The study found that replenishing one of the body’s most powerful antioxidants led to “significant lessening of symptoms like tremors as well as symptoms like dementia, depression, anxiety and hallucinations.”

This research proves what I’ve been telling my Parkinson’s patients for years… that supplementing with N-acetyl-cysteine (NAC) leads to dramatic improvements in dopamine function.

You see, Parkinson’s disease is a neurodegenerative disorder. When you have Parkinson’s, an area of your brain called the substantia nigra stops producing a neurotransmitter called dopamine.

And the less dopamine you make, the less control you have over your movements, your body and your emotions. You end up with classic Parkinson’s symptoms.

This breakdown of dopamine is caused by oxidative stress. But NAC stops this free-radical damage.

NAC works in two ways, it:

  1. Eases the physical symptoms of the disease
  2. Increases brain levels of dopamine

In the Jefferson study, 42 patients with Parkinson’s were divided into two groups. The first group received a combination of oral and intravenous (IV) of NAC for three months along with their prescribed drugs for Parkinson’s. The second group only took their regular prescriptions.

Both groups were given cognitive and motor function tests. At the end of three months they were tested again.

There was no improvement in the medication-only group. But in NAC patients, scores increased nearly 14%.

I’ve been treating my patients at the Sears Institute for Anti-Aging Medicine with NAC for years. In patients with very early-stage Parkinson’s, I recommend taking 600 mg of NAC every day in capsule form.

But in most cases, I take it one step further. I treat my Parkinson’s patients with a glutathione cocktail therapy.

Glutathione is your body’s master antioxidant. It fights the free radicals found in Parkinson’s patients. And studies show that sufferers of Parkinson’s have dangerously low levels of glutathione in their brains.

Here’s the link between the two… N-acetyl-cysteine is converted by the body into an amino acid called cysteine. In turn, cysteine helps produce glutathione. Boosting levels directly through an IV can guard against further damage and boost the function of surviving neurons.

A double-blind study of 45 people with mild to moderate Parkinson’s backs this up…

Researchers gave patients either a high or moderate dose of glutathione or a placebo. After three months, they tested the participants using the Unified Parkinson’s Disease Rating Scale. Those receiving a high dose once again had significant improvements in their total score, motor subscore and even non-motor subscore.2

The evidence of glutathione’s power is backed up in my own research and numerous scientific studies. Danish researchers compared people aged 100 to 105 with people aged 60 to 79 — and found the centenarians had much higher levels of glutathione. And those who were most active had the very highest levels.3

Glutathione increases energy, fights illness, increases mental clarity, reduces body fat, and protects against age-related decline.4

IV Therapy Gets Glutathione Directly Where You Need It

IV therapy works fast — often in under an hour. It allows the nutrients to bypass your digestive system and go directly into your cells. And bioavailability from IV is 100%.

At the Sears Institute, I customize an IV cocktail for every individual patient based on their needs. If you are interested in this therapy — for yourself or for your loved one with Parkinson’s — please call my clinic at 561-410-7854. My staff is happy to answer any questions you have.

To Your Good Health,

Al Sears, MD

Al Sears, MD, CNS

1. Monti DA, et al. “N-acetyl cysteine is associated with dopaminergic improvement in Parkinson’s disease.” Clin Pharmacol Ther. 2019 Jun 17. doi: 10.1002/cpt.1548. [Epub ahead of print] 2. Mischley LK, et al. “Phase IIb study of intranasal glutathione in Parkinson’s Disease.” J Parkinsons Dis. 2017;7(2):289–299.
3. Andersen HR, “Lower activity of superoxide dismutase and high activity of glutathione reductase in erythrocytes from centenarians.” Age Aging. 1998;27(5):643-648.
4. Richie JP, et al. “Correction of a glutathione deficiency in the aging mosquito increases its longevity.” Proc Soc Exp Biol Med. 1987;184(1):113-117.